CH EMED EPR
3.0.0 - trial-use Switzerland flag

This page is part of the FHIR eMedication exchange formats for the implementation effort of CARA within its EPR community (v3.0.0: STU3) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Changelog
... 3 Document Dis
... 4 Document Mtp
... 5 Document Padv
... 6 Document Pml
... 7 Document Pmlc
... 8 Document Pre
... 9 Guidance Amount Quantity
... 10 Guidance Comments
... 11 Guidance Compositions
... 12 Guidance Datatypes
... 13 Guidance Index
... 14 Guidance Others
... 15 Guidance Treatment
... 16 Use Case
... 17 Use Case Self Medication
... 18 Workflow
... 19 Artifacts Summary
.... 19.1 Body Weight Observation
.... 19.2 CH EMED EPR Device
.... 19.3 CH EMED EPR Medication
.... 19.4 CH EMED EPR Medication (DIS)
.... 19.5 CH EMED EPR Organization
.... 19.6 CH EMED EPR Patient
.... 19.7 CH EMED EPR Practitioner
.... 19.8 CH EMED EPR PractitionerRole
.... 19.9 CH EMED EPR RelatedPerson
.... 19.10 DIS Composition
.... 19.11 DIS Document
.... 19.12 DIS MedicationDispense
.... 19.13 MTP Composition
.... 19.14 MTP Document
.... 19.15 MTP MedicationStatement
.... 19.16 PADV Changed MedicationRequest
.... 19.17 PADV Changed MedicationStatement
.... 19.18 PADV Composition
.... 19.19 PADV Document
.... 19.20 PADV Observation
.... 19.21 PML Changed Medication Request
.... 19.22 PML Changed MedicationStatement
.... 19.23 PML Composition
.... 19.24 PML Document
.... 19.25 PML MedicationDispense
.... 19.26 PML MedicationRequest
.... 19.27 PML MedicationStatement
.... 19.28 PML Observation
.... 19.29 PMLC Composition
.... 19.30 PMLC Document
.... 19.31 PMLC MedicationStatement
.... 19.32 PRE Composition
.... 19.33 PRE Document
.... 19.34 PRE MedicationRequest
.... 19.35 Amount Quantity
.... 19.36 Amount Range
.... 19.37 Dosage (MedicationRequest)
.... 19.38 Dosage (MedicationStatement / MedicationDispense)
.... 19.39 Dosage Split
.... 19.40 Ratio (Amount / Amount)
.... 19.41 Ratio (Amount / Time)
.... 19.42 Time Quantity
.... 19.43 Amount Quantity Unit Codes
.... 19.44 Event Timings
.... 19.45 Paper Formats
.... 19.46 Route of Administration
.... 19.47 Substance Administration Substitution Codes
.... 19.48 Time Quantity Unit Codes
.... 19.49 CH EMED EPR Paper Format Code System
.... 19.50 CH EMED EPR - HCI Index CdTyp26 Naming System
.... 19.51 CH EMED EPR - HCI Index CdTyp9 Naming System
.... 19.52 CH EMED EPR - HUG DTN-IA Naming System
.... 19.53 CH EMED EPR - PMP-PID Assigning Authority OID dev
.... 19.54 CH EMED EPR CARA MPI Int Naming System
.... 19.55 CH EMED EPR CHUV Root Naming System
.... 19.56 CH EMED EPR HUG eHealth domain Naming System
.... 19.57 CH EMED EPR HUG Patient Id Assigning Authority (cert) Naming System
.... 19.58 CH EMED EPR HUG Patient Id Assigning Authority (dev) Naming System
.... 19.59 CH EMED EPR HUG Patient Id Assigning Authority (form) Naming System
.... 19.60 CH EMED EPR HUG Patient Id Assigning Authority (prod) Naming System
.... 19.61 CH EMED EPR HUG Root Naming System
.... 19.62 CdTyp26 -> RouteOfAdministrationEDQM
.... 19.63 CdTyp9 -> CHEMEDEPRAmountQuantityUnitCode
.... 19.64 CdTyp9 -> CHEMEDEPRTimeQuantityUnitCode
.... 19.65 CHEMEDEPRAmountQuantityUnitCode -> CdTyp9
.... 19.66 CHEMEDEPRTimeQuantityUnitCode -> CdTyp9
.... 19.67 RouteOfAdministrationEDQM -> CdTyp26
.... 19.68 Bundle: DIS 1
.... 19.69 Bundle: DIS for a self-medicating dafalgan treatment.
.... 19.70 Bundle: MTP 1
.... 19.71 Bundle: MTP Dafalgan Effervescent CARAPMP004
.... 19.72 Bundle: MTP for Marcoumar tabs 3mg with free text dosage
.... 19.73 Bundle: MTP for no branded ibuprofen.
.... 19.74 Bundle: MTP for self-medicating paracetamol.
.... 19.75 Bundle: MTP Paracetamol CARAPMP004
.... 19.76 Bundle: PADV 1
.... 19.77 Bundle: PADV 2
.... 19.78 Bundle: PADV CANCEL paracetamol Axapharm
.... 19.79 Bundle: PADV CHANGE paracetamol Axapharm
.... 19.80 Bundle: PML #1
.... 19.81 Bundle: PMLC document with a prescribed axapharm paracetamol treatment
.... 19.82 Bundle: PMLC document with a prescribed dafalgan effervescent paracetamol treatment
.... 19.83 Bundle: PMLC document with no treatments
.... 19.84 Bundle: PMLC #1
.... 19.85 Bundle: PMLC document with Dafalgan self-medication
.... 19.86 Bundle: PMLC document with Dafalgan self-medication
.... 19.87 Bundle: PRE 1
.... 19.88 Bundle: PRE Dafalgan eff 500mg
.... 19.89 Bundle: PRE Dafalgan eff 500mg
.... 19.90 Bundle: PRE Marcoumar tabs 3mg with alternating dosage
.... 19.91 Bundle: PRE Paracetamol Axapharm 1g
.... 19.92 Bundle: use case PML #1
.... 19.93 Bundle: use case PML #6b
.... 19.94 Changed Medication Statement: Triatec (PADV)
.... 19.95 Composition: use case PML #1
.... 19.96 Composition: use case PML #6b
.... 19.97 Device: PMP Aggregator
.... 19.98 Medication: Triatec
.... 19.99 MedicationDispense: Dafalgan self-medication
.... 19.100 MedicationDispense: Triatec (DIS)
.... 19.101 MedicationDispense: Triatec (PML)
.... 19.102 MedicationIbuprofen
.... 19.103 MedicationMarcoumar
.... 19.104 MedicationMarcoumar25TabsPackage
.... 19.105 MedicationNorvasc
.... 19.106 MedicationParacetamolAxapharm
.... 19.107 MedicationParacetamolDafalganEff
.... 19.108 MedicationRamipril
.... 19.109 MedicationRequest: Dafalgan effervescent 500mg (PRE)
.... 19.110 MedicationRequest: Dafalgan effervescent 500mg (PRE)
.... 19.111 MedicationRequest: Ibuprofen no branded details (PRE)
.... 19.112 MedicationRequest: Marcoumar 3mg tabs free text dosage
.... 19.113 MedicationRequest: Paracetamol Axapharm 1g (PML)
.... 19.114 MedicationRequest: Paracetamol Axapharm 1g (PRE)
.... 19.115 MedicationRequest: Triatec (PML)
.... 19.116 MedicationRequest: Triatec (PRE)
.... 19.117 MedicationStatement: ibuprofen, no brand
.... 19.118 MedicationStatement: Marcoumar cpr 3mg
.... 19.119 MedicationStatement: Paracetamol Axapharm (MTP)
.... 19.120 MedicationStatement: Paracetamol Axapharm (PML)
.... 19.121 MedicationStatement: Paracetamol Axapharm (PMLC)
.... 19.122 MedicationStatement: Paracetamol Dafalgan Effervescent (MTP)
.... 19.123 MedicationStatement: Paracetamol Dafalgan Effervescent (MTP) with max dose per period
.... 19.124 MedicationStatement: Paracetamol Dafalgan Effervescent (MTP) with split dose
.... 19.125 MedicationStatement: Paracetamol Dafalgan Effervescent (PMLC)
.... 19.126 MedicationStatement: self-medication paracetamol treatment
.... 19.127 MedicationStatement: Triatec (MTP)
.... 19.128 MedicationStatementCard: self-medication paracetamol treatment
.... 19.129 MedicationStatementCard: self-medication paracetamol treatment after dispense.
.... 19.130 MedicationWithATC
.... 19.131 MedicationWithTwoIngredients
.... 19.132 Observation: CANCEL of Axapharm paracetamol treatment.
.... 19.133 Observation: CHANGE of Axapharm paracetamol prescription, replaced with Dafalgan eff.
.... 19.134 Observation: CHANGE of Axapharm paracetamol prescription, replaced with Dafalgan eff.
.... 19.135 Observation: Ramipril (PADV)
.... 19.136 Observation: Triatec (PADV)
.... 19.137 Observation: Triatec (PML)
.... 19.138 Organization: CARA
.... 19.139 Organization: HUG
.... 19.140 Organization: Pharma SI
.... 19.141 Patient: Dupont
.... 19.142 Patient: Michaël Christopher KARCE
.... 19.143 Pharmacist: John Doe
.... 19.144 Practitioner: Perry Cox
.... 19.145 PractitionerRole: John Doe @ PharmaSI
.... 19.146 PractitionerRole: Perry Cox @ HUG